ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
66 hedge funds and large institutions have $157M invested in Adamas Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
66
Holding in Top 10
1
Calls
$912K
Puts
$745K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$2.81M | |
| 3 | +$1.48M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.16M |
| 5 |
Two Sigma Investments
New York
|
+$780K |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$3.75M | |
| 3 | -$1.44M | |
| 4 |
Morgan Stanley
New York
|
-$1.37M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.29M |